A Large-scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events In Patients With Polycythemia Vera (PV)

Trial Profile

A Large-scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events In Patients With Polycythemia Vera (PV)

Discontinued
Phase of Trial: Phase III

Latest Information Update: 19 Jul 2013

At a glance

  • Drugs Aspirin (Primary) ; Hydroxycarbamide (Primary)
  • Indications Polycythaemia vera
  • Focus Therapeutic Use
  • Acronyms CYTO-PV
  • Most Recent Events

    • 08 Dec 2012 Study presented at the 54th Annual Meeting of the American Society of Hematology (ASH - Abstract #4), according to a media release from the American Society of Hematology.
    • 08 Dec 2012 Results published in the New England Journal of Medicine.
    • 30 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top